PCG Advisory Group’s Jeff Ramson Featured on Regulation A+ Panel Discussion at 2017 Marcum MicroCap Conference
Highlights PCG Client, Myomo, Inc. Historic Reg A+ Offering on the NYSE
NEW YORK, NY–(Marketwired – Jun 16, 2017) – PCG Advisory Group (PCG), a leading investor relations and integrated communications agency, today announced its sponsorship of the 2017 Marcum MicroCap Conference held on June 15-16, 2017 at the Grand Hyatt Hotel, New York, New York.
PCG’s CEO and Founder, Jeff Ramson, appeared on an industry panel discussion for all conference attendees, titled: “Regulation A+: Two Years After the Creation of the “The Mini IPO.” The panel, held at 9:30 AM, June 16, 2017, featured Jeff and a team of industry experts, sharing their thoughts on how this significant change in capital raising has been utilized by the marketplace and was limited to conference participants.
Jeff Ramson states, “I am pleased to once again sponsor the 2017 Marcum MicroCap Conference and participate in this noteworthy panel discussion. My contribution to the discussion was certainly enhanced given PCG’s client and conference participant, Myomo Inc.’s recent IPO, as the first Regulation A+ issuer to list on the New York Stock Exchange MKT. I much appreciated taking part in the panel with industry leaders and sharing ideas on how companies can benefit from Regulation A+, which is a consequential change to federal securities law.”
About PCG Advisory Group:
Founded in 2008, PCG Advisory Group is dedicated to the delivery of top tier capital markets advisory services, strategic and tactical digital and social media communications, and cutting edge media and public relations for public and privately held companies. The team at PCG has extensive experience with life sciences and healthcare, high technology, metals and mining, financial services, and emerging growth companies from around the globe.
PCG’s Capital Markets Advisory Services include overall investor strategy development to increase and leverage investor awareness, visibility, and credibility.
PCG’s Social and Digital Media services include leveraging social and professional digital media sites to effectively and accurately communicate client stories. As an aggregation, distribution and engagement platform, PCG reaches thousands of individual, retail, and institutional investors using proprietary techniques, search engine optimization, online marketing, website development, and our proprietary and extensive distribution network. PCG’s Media and Public Relations services are a strategic and integral component of all Corporate Communications. The media and public relations team works with print, broadcast, online news sites, and bloggers to communicate the best client story at the right time. PCG also has the capabilities to assist a company during a merger, acquisition, or crisis.
Communicating the client’s story accurately and effectively is tantamount to maximizing exposure to its current and potential stakeholders.
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
About the Marcum MicroCap Conference
The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies under $500 million in market capitalization can network with the investment community. The conference features presentations by CEOs and CFOs from six principal industry sectors and provides investors with the opportunity to meet with management of these companies on a one-on-one basis. Industry sectors include Technology, Media & Internet; Software & Business Services; Life Science & Healthcare; Retail & Consumer Products; Energy & Natural Resources; and Industrials. The conference additionally includes a full agenda of panel discussions on issues of strategic importance to small cap issuers and investors, moderated by industry leaders.
The Marcum MicroCap Conference attracts fund managers and high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.